Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MET
MET
Merck KGaA nabs FDA “Breakthrough” tag for MET-targeting lung cancer drug
Pharmaforum
Wed, 09/11/19 - 11:48 pm
FDA
Merck KGaA
MET
lung cancer
tepotinib
non-small cell lung cancer